Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kasumov, Takhar ^a   Li, Ling ^a   Li, Min ^a   Gulshan, Kailash ^a   Kirwan, John P ^a   Liu, Xiuli ^a   Previs, Stephen ^b,c   Willard, Belinda ^a   Smith, Jonathan D ^a   McCullough, Arthur ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CERAMIDE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; SPHINGOMYELIN; THERMOZYMOCIDIN; VERY LOW DENSITY LIPOPROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MONOUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY LIVER; GENE EXPRESSION; INFLAMMATION; INSULIN SENSITIVITY; LIPOGENESIS; LIPOPROTEIN METABOLISM; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; WEIGHT GAIN; WESTERN DIET; ANIMAL; BLOOD; BODY WEIGHT; COMPLICATION; DEFICIENCY; DIET RESTRICTION; DRUG EFFECTS; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

MUS;

ANIMALS; APOLIPOPROTEINS B; APOPTOSIS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; BODY WEIGHT; CERAMIDES; CHOLESTEROL, HDL; DIET, WESTERN; FASTING; FATTY ACIDS, MONOUNSATURATED; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GLUCOSE; INFLAMMATION; INSULIN; LIVER CIRRHOSIS; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; RECEPTORS, LDL; RNA, MESSENGER;

EID: 84930640811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126910     Document Type: Article

References (62)

1. Alkhouri N, Tamimi TA, Yerian L, Lopez R, Zein NN, Feldstein AE. (2010) The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci 55:2644-2650. doi: 10.1007/s10620-009-1075-y PMID: 19960252
2. Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G. (2005) Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. ArteriosclerThromb Vasc Biol 25:2687-2688. PMID: 16306438
3. Parekh S, Anania FA (2007) Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132:2191-2207. PMID: 17498512
4. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47. PMID: 3513311
5. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ (2009) The metabolism and anti-atherogenic properties of HDL. J Lipid Res 50 Suppl: S195-200. doi: 10.1194/jlr. R800034-JLR200 PMID: 19033213
6. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355-1363. PMID: 15576296
7. Chavez JA, Siddique MM, Wang ST, Ching J, Shayman JA, Summers SA (2014) Ceramidesand Glucosylceramides are independent antagonists of insulin signaling. J Biol Chem 289:723-34. doi: 10. 1074/jbc. M113.522847 PMID: 24214972
8. Bikman BT (2012) Aroleforsphingolipids in the pathophysiology of obesity-induced inflammation. Cell Mol Life Sci 69:2135-2146. doi: 10.1007/s00018-012-0917-5 PMID: 22294100
9. Maceyka M, Spiegel S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510:58-67. doi: 10.1038/nature13475 PMID: 24899305
10. Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP (2012) Role of ceramidesin nonalcoholic fatty liver disease. Trends Endocrinol Metab 23:365-371. doi: 10.1016/j.tem.2012.04.005 PMID: 22609053
11. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, et al. (2009) Plasmaceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58:337-343. doi: 10.2337/db08-1228 PMID: 19008343
12. Huang H, Kasumov T, Gatmaitan P, Heneghan HM, Kashyap SR, Schauer PR, et al. (2011) Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) 19:2235-2240. doi: 10.1038/oby.2011.107 PMID: 21546935
13. Summers SA (2010) Sphingolipids and insulin resistance: the five Ws. CurrOpin Lipidol 21:128-135. doi: 10.1097/MOL0b013e3283373b66 PMID: 20216312
14. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, et al. (2000) Plasma sphingomyelin level as a risk factor for coronary artery disease. ArteriosclerThromb Vasc Biol 20:2614-2618. PMID: 11116061
15. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, et al. (1994) Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo) 47:208-215. PMID: 8150717
16. Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, et al. (2004) Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 110:3465-3471. PMID: 15545514
17. Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, et al. (2005) Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem 280:10284-10289. PMID: 15590644
18. Park TS, Panek RL, Rekhter MD, Mueller SB, Rosebury WS, Robertson A, et al. (2006) Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 189:264-272. PMID: 16458317
19. Kasumov T, Willard B, Li L, Li M, Conger H, Buffa JA, et al. (2013) 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice. Arterioscler Thromb Vasc Biol 33:1994-2003. doi: 10.1161/ATVBAHA.113.301700 PMID: 23766259
20. Heneghan HM, Huang H, Kashyap SR, Gornik HL, McCullough AJ, Schauer PR, et al. (2013) Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio. Surg Obes Relat Dis 9:100-107. doi: 10.1016/j.soard.2011.11.018 PMID: 22264909
21. Bieghs V, Van Gorp PJ, Wouters K, Hendrikx T, Gijbels MJ, Lutjohann D, et al. (2012) LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS One 7:e30668. doi: 10.1371/journal.pone.0030668 PMID: 22295101
22. Wu L, Vikramadithyan R, Yu S, Pau C, Hu Y, Goldberg IJ, et al. (2006) Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis. J Lipid Res 47:2215-2222. PMID: 16840797
23. Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, et al. (2011) Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52:1626-1635. doi: 10.1194/jlr. M016246 PMID: 21690266
24. Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, et al. (2010) Rosiglitazoneattenuates ageand diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology (Baltimore, Md) 52:2001-2011. doi: 10.1002/hep. 23941 PMID: 20938947
25. Joven J, Rull A, Ferrâe N, Escoláa-Gil JC, Marsillach J, Coll B, et al. (2007) The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 195:e85-92. PMID: 17651742
26. Deevska GM, Rozenova KA, Giltiay NV, Chambers MA, White J, Boyanovsky BB, et al. (2009) Acid Sphingomyelinase Deficiency Prevents Diet-induced HepaticTriacylglycerol Accumulation and Hyperglycemia in Mice. The Journal of biological chemistry 284:8359-8368. doi: 10.1074/jbc. M807800200 PMID: 19074137
27. Teupser D, Persky AD, Breslow JL (2003) Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arteriosclerosis, thrombosis, and vascular biology 23:1907-1913. PMID: 12907460
28. Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, et al. (2008) Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes 57:1674-1682. doi: 10.2337/db08-0083 PMID: 18346984
29. Brunengraber DZ, McCabe BJ, Kasumov T, Alexander JC, Chandramouli V, Previs SF (2003) Influence of diet on the modeling of adipose tissue triglycerides during growth. Am J Physiol Endocrinol Metab 285:E917-925. PMID: 12799315
30. Li L, Willard B, Rachdaoui N, Kirwan JP, Sadygov RG, Stanley WC, et al. (2012) Plasmaproteomedynamics: analysis of lipoproteins and acute phase response proteins with 2H2O metabolic labeling. Mol Cell Proteomics 11:M111 014209.
31. Siri P, Candela N, Zhang YL, Ko C, Eusufzai S, Ginsberg HN, et al. (2001) Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem 276:46064-46072. PMID: 11598138
32. Kasumov T, Huang H, Chung YM, Zhang R, McCullough AJ, Kirwan JP (2010) Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 401:154-161. doi: 10.1016/j.ab.2010.02.023 PMID: 20178771
33. Kasumov T, Sharma N, Huang H, Kombu RS, Cendrowski A, Stanley WC, et al. (2009) Dipropionylcysteine ethyl ester compensates for loss of citric acid cycle intermediates during post ischemia reperfusion in the pig heart. Cardiovasc Drugs Ther 23:459-469. doi: 10.1007/s 10557-009-6208-1 PMID: 19967553
34. Shah V, Herath K, Previs SF, Hubbard BK, Roddy TP (2010) Headspace analyses of acetone: a rapid method for measuring the 2H-labeling of water. Anal Biochem 404:235-237. doi: 10.1016/j.ab.2010.05.010 PMID: 20488158
35. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917. PMID: 13671378
36. Previs SF, Mahsut A, Kulick A, Dunn K, Andrews-Kelly G, Johnson C, et al. (2011) Quantifying cholesterol synthesis in vivo using (2) H (2) O: enabling back-to-back studies in the same subject. J Lipid Res 52:1420-1428. doi: 10.1194/jlr. D014993 PMID: 21498887
37. Baglione J, Smith JD (2006) Quantitative assay for mouse atherosclerosis in the aortic root. Methods Mol Med 129:83-95. PMID: 17085806
38. Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Kahn CR, et al. (2007) Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 282:23829-23840. PMID: 17545163
39. Deevska GM, Sunkara M, Morris AJ, Nikolova-Karakashian MN (2012) Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/-mice fed on a high-fat diet. Biosci Rep 32:479-490. doi: 10.1042/BSR20120036 PMID: 22712892
40. Zhou H, Li W, Wang SP, Mendoza V, Rosa R, Hubert J, et al. (2012) Quantifying apoprotein synthesis in rodents: coupling LC-MS/MS analyses with the administration of labeled water. J Lipid Res 53:1223-1231. doi: 10.1194/jlr. D021295 PMID: 22389331
41. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G (2004) Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 27:2498-2500. PMID: 15451925
42. Wouters K, Van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, et al. (2008) Dietary cholesterol, ratherthan liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474-486. doi: 10.1002/hep. 22363 PMID: 18666236
43. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, et al. (2009) Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104:e42-54. doi: 10.1161/CIRCRESAHA.108.188771 PMID: 19265038
44. Teupser D, Persky AD, Breslow JL (2003) Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 23:1907-1913. PMID: 12907460
45. Boon J, Hoy AJ, Stark R, Brown RD, Meex RC, Henstridge DC, et al. (2013) Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62:401-410. doi: 10.2337/db12-0686 PMID: 23139352
46. Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, et al. (2014) Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20:678-686. doi: 10.1016/j.cmet.2014.08.002 PMID: 25295788
47. Levy M, Futerman AH (2010) Mammalian ceramide synthases. IUBMB Life 62:347-356. doi: 10.1002/iub.319 PMID: 20222015
48. Pewzner-Jung Y, Brenner O, Braun S, Laviad EL, Ben-Dor S, Feldmesser E, et al. (2010) A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy. J Biol Chem 285:10911-10923. doi: 10.1074/jbc. M109.077610 PMID: 20110366
49. Raichur S, Wang ST, Chan PW, Li Y, Ching J, Chaurasia B, et al. (2014) CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab 20:687-695. doi: 10.1016/j.cmet.2014.09.015 PMID: 25295789
50. Park JW, Park WJ, Kuperman Y, Boura-Halfon S, Pewzner-Jung Y, Futerman AH. (2013) Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 57:525-532. doi: 10.1002/hep. 26015 PMID: 22911490
51. Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, et al. (2015) IntestinalfarnesoidX receptorsignaling promotes nonalcoholic fatty liver disease. J Clin Invest 125:386-402. doi: 10.1172/JCI76738 PMID: 25500885
52. Scarpa MC, Baraldo S, Marian E, Turato G, Calabrese F, Saetta M, et al. (2013) Ceramide expression and cell homeostasis in chronic obstructive pulmonary disease. Respiration 85:342-349. doi: 10. 1159/000341185 PMID: 23018286
53. Dekker MJ, Baker C, Naples M, Samsoondar J, Zhang R, Qiu W, et al. (2013) Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. Atherosclerosis 228:98-109. doi: 10.1016/j.atherosclerosis.2013.01.041 PMID: 23466071
54. Gulshan K, Brubaker G, Wang S, Hazen SL, Smith JD (2013) Sphingomyelin depletion impairs anionic phospholipid inward translocation and induces cholesterol efflux. J Biol Chem 288:37166-37179. doi:10.1074/jbc. M113.512244 PMID: 24220029
55. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, et al. (2012) Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61:1848-1859. doi: 10.2337/db11-1399 PMID: 22586587
56. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50:574-585. doi:10.1194/jlr. D800028-JLR200 PMID: 18832345
57. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, et al. (1994) Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arteriosclerosis and thrombosis: ajournal of vascular biology/American Heart Association 14:1767-1774.
58. Hoff HF, O'Neil J, Pepin JM, Cole TB (1990) Macrophage uptake of cholesterol-containing particles derived from LDLand isolated from atherosclerotic lesions. European heart journal 11:105-115. PMID: 2151186
59. Li Z, Park TS, Li Y, Pan X, Iqbal J, Lu D, et al. (2009) Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol. BiochimBiophysActa 1791:297-306. doi: 10.1016/j.bbalip. 2009.01.010 PMID: 19416652
60. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, et al. (2005) The target of ezetimibeis Niemann-PickC1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132-8137. PMID: 15928087
61. Abumurad NA, Sfeir Z (2000) Lipid transporters: membrane transport systems for cholesterol and fatty acids. CurrOpinClin Nutr Metab Care 3:255-262. PMID: 10929670
62. Ehehalt R, Sparla R, Kulaksiz H, Herrmann T, Fullekrug J, Stremmel W (2008) Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts). BMC Cell Biol 9:45. doi: 10.1186/1471-2121-9-45 PMID: 18700980